Model‐Informed Dosing Regimen of Sugemalimab for European Patients With Non‐Small Cell Lung Cancer: Bridging From Asian Clinical Data

Yucheng Sheng, Zenglian Yue, Fengyan Xu, Kun Wang, Jingru Wang, Qingmei Shi

Open source

DOI: 10.1002/psp4.70220
Published: 2026-02-26
Container: CPT: Pharmacometrics & Systems Pharmacology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/psp4.70220,
  title = {Model‐Informed Dosing Regimen of Sugemalimab for European Patients With Non‐Small Cell Lung Cancer: Bridging From Asian Clinical Data},
  author = {Yucheng Sheng and Zenglian Yue and Fengyan Xu and Kun Wang and Jingru Wang and Qingmei Shi},
  year = {2026},
  journal = {CPT: Pharmacometrics \&amp; Systems Pharmacology},
  doi = {10.1002/psp4.70220},
  url = {https://doi.org/10.1002/psp4.70220}
}

RIS

TY  - JOUR
TI  - Model‐Informed Dosing Regimen of Sugemalimab for European Patients With Non‐Small Cell Lung Cancer: Bridging From Asian Clinical Data
AU  - Yucheng Sheng
AU  - Zenglian Yue
AU  - Fengyan Xu
AU  - Kun Wang
AU  - Jingru Wang
AU  - Qingmei Shi
PY  - 2026
JO  - CPT: Pharmacometrics &amp; Systems Pharmacology
DO  - 10.1002/psp4.70220
UR  - https://doi.org/10.1002/psp4.70220
ER  -

APA

Sheng, Y., Yue, Z., Xu, F., Wang, K., Wang, J., & Shi, Q. (2026). Model‐Informed Dosing Regimen of Sugemalimab for European Patients With Non‐Small Cell Lung Cancer: Bridging From Asian Clinical Data. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70220

Source records

crossref · retrieved 2026-09-26T01:17:44.960Z